Bausch + Lomb Corp (BLCO) concluded trading on Wednesday at a closing price of $11.56, with 4.13 million shares of worth about $47.76 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -43.50% during that period and on April 30, 2025 the price saw a loss of about -15.74%. Currently the company’s common shares owned by public are about 350.91M shares, out of which, 36.69M shares are available for trading.
Stock saw a price change of -9.26% in past 5 days and over the past one month there was a price change of -20.28%. Year-to-date (YTD), BLCO shares are showing a performance of -35.99% which decreased to -21.84% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.46 but also hit the highest price of $21.69 during that period. The average intraday trading volume for Bausch + Lomb Corp shares is 732.31K. The stock is currently trading -7.33% below its 20-day simple moving average (SMA20), while that difference is down -19.33% for SMA50 and it goes to -32.39% lower than SMA200.
Bausch + Lomb Corp (NYSE: BLCO) currently have 350.91M outstanding shares and institutions hold larger chunk of about 9.27% of that.
The stock has a current market capitalization of $4.08B and its 3Y-monthly beta is at 0.55. It has posted earnings per share of -$0.90 in the same period. It has Quick Ratio of 1.01 while making debt-to-equity ratio of 0.76. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BLCO, volatility over the week remained 5.92% while standing at 6.87% over the month.
Stock’s fiscal year EPS is expected to drop by -10.61% while it is estimated to increase by 44.42% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on March 28, 2025 offering an Equal weight rating for the stock and assigned a target price range of between $24 and $15 to it. Coverage by Citigroup stated Bausch + Lomb Corp (BLCO) stock as a Neutral in their note to investors on December 11, 2024, suggesting a price target of $22 for the stock. On December 02, 2024, Morgan Stanley Downgrade their recommendations, while on October 15, 2024, Evercore ISI Upgrade their ratings for the stock with a price target of $25. Stock get an Outperform rating from Raymond James on July 10, 2024.
